Gong, Wenjie http://orcid.org/0000-0001-6965-6209
Hoffmann, Jean-Marc
Stock, Sophia
Wang, Lei
Liu, Yibin
Schubert, Maria-Luisa
Neuber, Brigitte
Hückelhoven-Krauss, Angela
Gern, Ulrike
Schmitt, Anita
Müller-Tidow, Carsten
Shiku, Hiroshi
Schmitt, Michael
Sellner, Leopold
Funding for this research was provided by:
Government of Baden-Württemberg
Deutsches Konsortium für Translationale Krebsforschung
Deutsches Krebsforschungszentrum
Medizinischen Fakultät Heidelberg, Universität Heidelberg
NCT Heidelberg School of Oncology
the German Society of Internal Medicine
Article History
Received: 26 October 2018
Accepted: 3 June 2019
First Online: 8 June 2019
Compliance with ethical standards
:
: The authors declare that there are no conflicts of interest.
: The research was approved by the Ethics Committee of the University of Heidelberg (S-254/2016). All studies involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Written informed consent for the use of their blood for research purposes was obtained from all healthy donors by the Blood Bank Heidelberg.
: The soft-tissue sarcoma cell lines SW982 (HLA-A2-positive NY-ESO-1-positive), SYO-1 (HLA-A2-negative NY-ESO-1-negative), Fuji (HLA-A2-positive NY-ESO-1-negative) and MLS-1765-92 (HLA-A2-negative NY-ESO-1-positive) were provided by Prof. H. Shiku (Mie University, Tsu, Japan). All cell lines were authenticated at DSMZ (German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany).